Page last updated: 2024-08-22

tranylcypromine and Central Nervous System Disease

tranylcypromine has been researched along with Central Nervous System Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Almeida, AJ; Duarte, D; Gonçalves, LM; Marto, J; Silva, S; Soares, OSGP; Vale, N; Vasques-Nóvoa, F1
HIRSCHMANN, J; MAYER, K1
Corkeron, MA1
Gillman, PK1

Other Studies

4 other study(ies) available for tranylcypromine and Central Nervous System Disease

ArticleYear
New Peptide Functionalized Nanostructured Lipid Carriers with CNS Drugs and Evaluation Anti-proliferative Activity.
    International journal of molecular sciences, 2022, Jun-26, Volume: 23, Issue:13

    Topics: Caco-2 Cells; Cell-Penetrating Peptides; Central Nervous System Diseases; Drug Carriers; Humans; Lipids; Nanoparticles; Nanostructures; Particle Size; Tranylcypromine

2022
[NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS].
    Arzneimittel-Forschung, 1964, Volume: 14

    Topics: Central Nervous System Diseases; Dihydroxyphenylalanine; Drug Therapy; Electroencephalography; Extrapyramidal Tracts; Humans; Movement Disorders; Parkinsonian Disorders; Tranylcypromine

1964
Serotonin syndrome--a potentially fatal complication of antidepressant therapy.
    The Medical journal of Australia, 1995, Nov-06, Volume: 163, Issue:9

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Central Nervous System Diseases; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Tranylcypromine

1995
Successful treatment of serotonin syndrome with chlorpromazine.
    The Medical journal of Australia, 1996, Sep-16, Volume: 165, Issue:6

    Topics: Central Nervous System Diseases; Chlorpromazine; Clomipramine; Depression; Drug Interactions; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome; Tranylcypromine

1996